CA71618/CA/NCI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1998	1
2000	5
2001	6
2002	6
2003	4
2004	8
2005	5
2006	5
2007	3
2008	3
2022	0

1

3p21.3 tumor suppressor cluster: prospects for translational applications.

Ji L, Minna JD, Roth JA. Ji L, et al. Future Oncol. 2005 Feb;1(1):79-92. doi: 10.1517/14796694.1.1.79. Future Oncol. 2005. PMID: 16555978 Review.

2

Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers.

Zabarovsky ER, Lerman MI, Minna JD. Zabarovsky ER, et al. Oncogene. 2002 Oct 7;21(45):6915-35. doi: 10.1038/sj.onc.1205835. Oncogene. 2002. PMID: 12362274 Review.

3

Beta-catenin inhibits cell growth of a malignant mesothelioma cell line, NCI-H28, with a 3p21.3 homozygous deletion.

Usami N, Sekido Y, Maeda O, Yamamoto K, Minna JD, Hasegawa Y, Yoshioka H, Imaizumi M, Ueda Y, Takahashi M, Shimokata K. Usami N, et al. Oncogene. 2003 Sep 11;22(39):7923-30. doi: 10.1038/sj.onc.1206533. Oncogene. 2003. PMID: 12970740

4

Genetic and epigenetic inactivation of LTF gene at 3p21.3 in lung cancers.

Iijima H, Tomizawa Y, Iwasaki Y, Sato K, Sunaga N, Dobashi K, Saito R, Nakajima T, Minna JD, Mori M. Iijima H, et al. Int J Cancer. 2006 Feb 15;118(4):797-801. doi: 10.1002/ijc.21462. Int J Cancer. 2006. PMID: 16152584 Free article.

5

Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion.

Shigemitsu K, Sekido Y, Usami N, Mori S, Sato M, Horio Y, Hasegawa Y, Bader SA, Gazdar AF, Minna JD, Hida T, Yoshioka H, Imaizumi M, Ueda Y, Takahashi M, Shimokata K. Shigemitsu K, et al. Oncogene. 2001 Jul 12;20(31):4249-57. doi: 10.1038/sj.onc.1204557. Oncogene. 2001. PMID: 11464291

6

RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers.

Gao B, Xie XJ, Huang C, Shames DS, Chen TT, Lewis CM, Bian A, Zhang B, Olopade OI, Garber JE, Euhus DM, Tomlinson GE, Minna JD. Gao B, et al. Cancer Res. 2008 Jan 1;68(1):22-5. doi: 10.1158/0008-5472.CAN-07-5183. Cancer Res. 2008. PMID: 18172292 Free PMC article.

7

The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer.

Sekine I, Sato M, Sunaga N, Toyooka S, Peyton M, Parsons R, Wang W, Gazdar AF, Minna JD. Sekine I, et al. Oncogene. 2005 Apr 14;24(16):2735-8. doi: 10.1038/sj.onc.1207694. Oncogene. 2005. PMID: 15735765

8

CACNA2D2-mediated apoptosis in NSCLC cells is associated with alterations of the intracellular calcium signaling and disruption of mitochondria membrane integrity.

Carboni GL, Gao B, Nishizaki M, Xu K, Minna JD, Roth JA, Ji L. Carboni GL, et al. Oncogene. 2003 Jan 30;22(4):615-26. doi: 10.1038/sj.onc.1206134. Oncogene. 2003. PMID: 12555074 Free PMC article.

9

Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins.

Ramirez RD, Sheridan S, Girard L, Sato M, Kim Y, Pollack J, Peyton M, Zou Y, Kurie JM, Dimaio JM, Milchgrub S, Smith AL, Souza RF, Gilbey L, Zhang X, Gandia K, Vaughan MB, Wright WE, Gazdar AF, Shay JW, Minna JD. Ramirez RD, et al. Cancer Res. 2004 Dec 15;64(24):9027-34. doi: 10.1158/0008-5472.CAN-04-3703. Cancer Res. 2004. PMID: 15604268

10

The growth and tumor suppressor NORE1A is a cytoskeletal protein that suppresses growth by inhibition of the ERK pathway.

Moshnikova A, Frye J, Shay JW, Minna JD, Khokhlatchev AV. Moshnikova A, et al. J Biol Chem. 2006 Mar 24;281(12):8143-52. doi: 10.1074/jbc.M511837200. Epub 2006 Jan 18. J Biol Chem. 2006. PMID: 16421102 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results